Welcome to AVATAR Group

One in four catheters fail due to infection, blockage or dislodgement - this effects 40% of hospital patients. One in five catheters are in place despite no clinical need. The AVATAR Group undertakes committed scientific work to improve hospital and home care practices, to rigorously and independently test new products, and to promote global networks of vascular access researchers. Patients experiencing medical treatment and needing IV catheters (including venous and arterial, central and peripheral, dialysis, chemotherapy, nutrition and cardiac care) benefit from reduced complications and a better experience of their IV treatment.

The AVATAR Group works to eliminate ineffective practices, and replace them with innovative solutions - saving global healthcare providers hundreds of millions of dollars per year. 


Griffith University
Australia 4111